Research Peptide COA Guide 2026: How to Read HPLC, Mass Spectrometry, Purity & Batch Testing

A Certificate of Analysis (COA) is one of the most useful documents for evaluating a research peptide, but only if you know how to read it. A good COA can connect a specific batch to analytical testing for identity and purity; a vague “99% pure” claim without batch information tells you far less.

That distinction becomes particularly important when comparing research materials such as retatrutide, cagrilintide, semaglutide, and tirzepatide, where molecular identity, analytical purity, lot traceability, and intended research use all matter.

For researchers evaluating current American Peptides materials, the company's COA library currently lists lot-matched certificates for compounds including retatrutide, retatrutide + cagrilintide, semaglutide, and tirzepatide, and states that batches are independently tested for identity and purity using HPLC/mass spectrometry. ([American Peptides][1])

If you're also comparing current acquisition costs after you've established that the material meets your research requirements, the supplied American Peptides promotion is LOOT10, advertised as providing up to 30% off. The offer page is American Peptides LOOT10 offer.

What Is a Certificate of Analysis for a Research Peptide?

A Certificate of Analysis is a laboratory document describing analytical results obtained from a particular sample or batch.

For research peptides, a useful COA may contain information such as:

Compound name
Lot or batch number
Test date
Analytical laboratory
HPLC purity
Mass-spectrometry result
Molecular weight
Appearance
Acceptance criteria
Individual analytical results
Additional quality tests

The most important concept is traceability.

A generic document saying:

Peptide X — 99% purity

is not equivalent to:

Peptide X — Lot ABC123 — HPLC result X — MS result Y — tested on a specified date.

The second document gives you something you can actually connect to a physical batch.

The Five Questions Every COA Should Help Answer

Before looking at tiny numbers and technical terminology, ask five simple questions:

What compound was tested?
Which batch was tested?
Who tested it?
What analytical methods were used?
What were the actual results?

If a COA cannot answer most of those questions, its value for research-quality assessment is limited.

This is also why current community discussions about peptide sourcing tend to emphasize batch-specific documentation, HPLC, mass spectrometry, and verification rather than relying solely on supplier reputation. ([Reddit][2])

How to Read the Top of a Peptide COA

The header is easy to skip.

Don't.

It establishes the identity of the document itself.

Look for:

Compound name

The name should correspond with the product you are evaluating.

For example:

Retatrutide

should not suddenly become an ambiguous label such as:

Metabolic peptide blend

unless you specifically intended to purchase a blend.

Lot number

The lot number should be traceable to the vial or product batch.

Test date

This tells you when the reported analysis was performed.

Laboratory

Ideally, the document should identify who performed the analysis.

Certificate number

Some laboratories assign unique report or certificate numbers.

That can make documents easier to track.

Why the Lot Number Is So Important

Think of the lot number as the bridge between the COA and the vial.

Without that bridge, the document may only tell you that a supplier has tested some version of the product.

With a matching lot number, you can ask:

“Is this the analytical result for the material I actually received?”

That is a much stronger question.

American Peptides currently publishes multiple lot-specific COAs for its research compounds. For example, its current COA library lists separate retatrutide lots and multiple semaglutide and tirzepatide lots rather than relying solely on one generic certificate for each compound. ([American Peptides][1])

HPLC: What Does Peptide Purity Testing Actually Mean?

HPLC stands for high-performance liquid chromatography.

It is one of the most common analytical techniques used to characterize peptide purity.

At a simplified level, HPLC separates components within a sample based on their interactions with the chromatographic system.

The resulting chromatogram can contain:

a dominant principal peak,
smaller related peaks,
impurities,
degradation products,
or other detectable components.

The reported purity percentage is generally derived from the analytical method used.

So when a COA says:

Purity: 99.5%

the useful follow-up question is:

99.5% according to which analytical method?

That is why the method belongs alongside the number.

What HPLC Can Tell You

Depending on the method, HPLC can provide evidence about:

chromatographic purity,
the principal peptide component,
related peaks,
and sample composition.

It can therefore be extremely useful for comparing research-peptide batches.

But it is not a universal quality certificate.

A high HPLC result does not automatically establish:

sterility,
endotoxin status,
absence of every contaminant,
clinical efficacy,
pharmaceutical equivalence,
or regulatory approval.

That distinction is essential.

Mass Spectrometry: The Identity Side of the Equation

Mass spectrometry, commonly abbreviated MS, provides information about molecular mass.

For a peptide, that makes it useful for checking whether the measured molecular mass is consistent with the expected molecule.

The simplified comparison is:

HPLC → purity profile

Mass spectrometry → molecular-mass/identity evidence

They answer related but different questions.

That is why a COA containing both can be considerably more informative than a document containing only a single purity number.

American Peptides currently describes its testing for listed research compounds as including HPLC and mass spectrometry, with lot-matched COAs available through its documentation library. ([American Peptides][1])

HPLC vs Mass Spectrometry: Quick Comparison

Test	Primary purpose	What it helps establish
HPLC	Chromatographic separation	Purity/profile
Mass spectrometry	Molecular-mass analysis	Identity/mass consistency
SDS	Safety documentation	Handling and hazard information
Additional assays	Compound-specific quality questions	Depends on method

The mistake is treating one test as though it replaces all the others.

It doesn't.

What Does “99% Pure” Actually Mean?

This is one of the most misunderstood phrases in online peptide research.

If a COA reports:

≥99% purity

that is an analytical result under a particular test method.

It does not mean:

99% guaranteed biological activity

or:

99% pharmaceutical quality

or:

99% sterile

or:

99% safe for human use.

Those are entirely different claims.

Purity should therefore always be read together with:

method,
sample,
lot,
laboratory,
and testing date.

Why 99% vs 99.9% Isn't the Whole Story

A supplier may advertise:

99.9% purity

while another reports:

99.0% purity.

It is tempting to immediately conclude that the first supplier is better.

But first ask:

Were the same analytical methods used?
Were the same acceptance criteria used?
Were the results independently verified?
Are the COAs lot-matched?
Are the laboratories identified?
Are the test dates current?
Is the compound actually the same structural entity?

A single decimal place cannot answer all of those questions.

Evidence quality matters alongside the purity number.

How to Spot a Strong COA

A strong COA generally has several characteristics.

1. Clear compound identity

The compound is explicitly named.

2. Clear batch identity

A lot number is provided.

3. Testing date

You know when the material was analyzed.

4. Analytical method

The document tells you what was actually measured.

5. Actual results

You can see numbers rather than only “PASS.”

6. Laboratory information

The testing source is identifiable.

7. Consistent specifications

The molecular information makes sense for the named compound.

8. Traceability

The COA can be connected to a specific product lot.

These characteristics are more useful than a page covered with generic quality slogans.

What a Weak COA Looks Like

There are several warning signs.

A document deserves closer scrutiny if it:

contains no lot number,
gives no test date,
does not identify the testing laboratory,
says only “PASS,”
gives a purity percentage without an analytical method,
uses inconsistent molecular information,
cannot be connected to the product batch,
or appears to be a generic certificate reused across multiple lots.

One red flag does not automatically establish that a supplier's material is poor.

But multiple missing pieces should reduce your confidence.

Does a COA Prove the Material Is Authentic?

Not by itself.

A COA is evidence.

The strength of that evidence depends on its provenance and traceability.

The strongest chain looks something like:

Supplier

↓

Specific lot

↓

Independent laboratory

↓

Analytical test

↓

COA

↓

Matching physical batch

That is substantially more useful than:

Website claim

↓

“99% pure”

What Does “Third-Party Tested” Mean?

Third-party testing generally means an external laboratory performs the relevant analytical work rather than the supplier relying exclusively on its own internal testing.

This can add an important layer of independence.

But even the phrase “third-party tested” deserves a follow-up question:

Which third party?

Ideally, you should be able to determine:

laboratory identity,
test method,
test date,
sample or lot identity,
and analytical result.

A named and traceable laboratory is more informative than an anonymous statement that testing occurred.

Should You Verify the Testing Laboratory?

For research where analytical confidence matters, independent verification can be worthwhile.

If a supplier provides a laboratory name or report identifier, look for ways to confirm that the documentation is consistent with the laboratory's own records or reporting system.

This is especially useful when:

the experiment is expensive,
the compound is difficult to source,
the results need to be reproduced,
or the material will be used as a reference standard.

A supplier COA and independent verification are not competing ideas.

They are different layers of evidence.

What Is a Lot-Matched COA?

A lot-matched COA is a certificate associated with a particular production or supply batch.

For example:

Product: Retatrutide Lot: RETA10-0616 Test: HPLC/MS Result: documented on certificate

The important part isn't the exact naming convention.

It is the connection between:

document ↔ batch

American Peptides' current COA library explicitly describes its certificates as lot-matched and lists multiple certificates for its retatrutide, semaglutide, tirzepatide, and other research compounds. ([American Peptides][1])

Why Batch-to-Batch Consistency Matters

Imagine running an experiment in January and repeating it in July.

If you use different lots, you have introduced another variable.

That does not automatically make the experiment invalid.

But it creates a question:

Were the analytical characteristics of the two lots sufficiently consistent?

This is why lot documentation can become important for reproducibility.

For a serious research programme, maintaining records of:

supplier,
compound,
lot,
COA,
storage,
preparation,
and experimental conditions

creates a much stronger audit trail.

What Does an SDS Tell You?

A Safety Data Sheet, or SDS, is different from a COA.

A COA focuses primarily on analytical characterization.

An SDS provides safety-related information such as:

hazards,
handling,
storage,
accidental-release procedures,
protective measures,
and other standardized safety information.

A research supplier that provides both gives researchers two different documentation layers.

American Peptides currently lists SDS documents alongside COAs for several of its research products. ([American Peptides][1])

COA vs SDS

Document	Main purpose
COA	Analytical characterization
SDS	Safety and handling
Product specification	Product identity and characteristics
Research literature	Scientific context
Regulatory documentation	Legal/regulatory status

Don't use an SDS as a substitute for a COA.

Don't use a COA as a substitute for an SDS.

They serve different purposes.

What Should You Look for in a Peptide Specification Sheet?

A useful specification page can include:

compound name,
CAS number,
molecular formula,
molecular weight,
amino-acid count,
sequence or structural description,
physical form,
purity specification,
storage conditions,
and intended research use.

For example, the current American Peptides retatrutide listing identifies it as a 39-residue peptide and provides a molecular formula, molecular weight, CAS number, physical form, purity specification, and storage information. ([American Peptides][3])

The current tirzepatide listing likewise provides molecular formula, molecular weight, amino-acid count, structural description, physical form, purity specification, and storage information. ([American Peptides][4])

That level of detail is much more useful than simply labeling a vial “research peptide.”

Retatrutide: What to Check on Its COA

Retatrutide is an especially good example because it is structurally complex and has attracted significant scientific interest.

The current American Peptides listing identifies retatrutide as:

CAS: 2381089-83-2
Molecular weight: approximately 4,731.2 g/mol
39 amino acids
Lyophilized powder
≥99% purity specification
HPLC and mass-spectrometry verification

The listing also identifies it as a GIP/GLP-1/glucagon triple agonist and provides lot-specific COA links. ([American Peptides][3])

For a retatrutide COA, therefore, don't just look for “99%.”

Check whether the analytical documentation is consistent with the expected molecular identity.

Semaglutide: What to Check on Its COA

Semaglutide is a useful comparison because it has a different molecular and receptor profile.

The current American Peptides documentation lists semaglutide as a research-use peptide and provides lot-specific COAs and an SDS. ([American Peptides][5])

When evaluating the document, check:

compound name,
lot,
analytical purity,
mass data,
test date,
laboratory,
and whether the physical batch matches the certificate.

Again, the question is not simply:

“Does it say 99%?”

It is:

“What evidence supports the identity and purity of this particular batch?”

Tirzepatide: What to Check on Its COA

The current American Peptides tirzepatide listing identifies:

CAS: 2023788-19-2
Molecular weight: approximately 4,813.45 g/mol
39 amino acids
GIP/GLP-1 dual-agonist architecture
lyophilized physical form,
≥99% HPLC purity specification,
and lot-specific COAs. ([American Peptides][4])

Because tirzepatide is structurally engineered and lipidated, molecular identity and purity should be considered together rather than treating the purity number as the entire analytical story.

Cagrilintide: Why It Needs Separate Consideration

Cagrilintide should not simply be treated as another GLP-1 peptide.

It is an amylin analogue, making its pharmacological architecture different from semaglutide, tirzepatide, and retatrutide.

That means a research comparison should preserve the molecular distinction.

The related guide in your topical cluster is:

Cagrilintide research guide 2026

And the retatrutide/cagrilintide combination reference is:

Retatrutide + Cagrilintide research guide

Why the Same COA Standard Should Be Used Across Suppliers

One of the easiest ways to produce a bad supplier comparison is to change the standard for each vendor.

For example:

Supplier A: judged on price.

Supplier B: judged on purity.

Supplier C: judged on reviews.

That isn't a fair comparison.

Use the same checklist for everyone:

Criterion	Supplier A	Supplier B	Supplier C
Lot-matched COA	✓ / ✗	✓ / ✗	✓ / ✗
HPLC	✓ / ✗	✓ / ✗	✓ / ✗
MS	✓ / ✗	✓ / ✗	✓ / ✗
Named lab	✓ / ✗	✓ / ✗	✓ / ✗
Test date	✓ / ✗	✓ / ✗	✓ / ✗
SDS	✓ / ✗	✓ / ✗	✓ / ✗
Storage data	✓ / ✗	✓ / ✗	✓ / ✗
RUO labeling	✓ / ✗	✓ / ✗	✓ / ✗
Additional testing	✓ / ✗	✓ / ✗	✓ / ✗
Transparent pricing	✓ / ✗	✓ / ✗	✓ / ✗

That makes the comparison much harder to manipulate.

Why Price Should Come Last

A $50 vial isn't necessarily a better deal than a $70 vial.

The useful question is:

What evidence and material characteristics am I receiving for the price?

A practical buying sequence is:

Define the research requirement.
Confirm compound identity.
Review the specification.
Review the lot-matched COA.
Check HPLC.
Check mass spectrometry.
Review additional testing.
Check SDS and storage information.
Confirm quantity.
Compare final price.

Only after the quality criteria are satisfied does a promotion become meaningful.

Current American Peptides Pricing Context

American Peptides currently lists five products in its GLP-1 & metabolic research collection:

Retatrutide
Cagrilintide
Retatrutide + Cagrilintide
Semaglutide
Tirzepatide

The current collection page shows displayed starting prices of approximately $105 for retatrutide, $170 for cagrilintide, $200 for the retatrutide/cagrilintide combination, $90 for semaglutide, and $100 for tirzepatide. Prices and configurations can change. ([American Peptides][6])

For retatrutide specifically, the current listing shows volume pricing beginning at 3–4 units and additional quantity tiers. ([American Peptides][3])

That means a researcher comparing acquisition costs should calculate the actual final cart price, not rely solely on the headline unit price.

Where LOOT10 Fits Into the Purchasing Decision

After you've checked the COA and determined that the material is appropriate for the research project, the supplied promotion can be considered as a cost-saving variable.

Promo code: LOOT10

Advertised discount: up to 30% off

Current offer: American Peptides LOOT10 offer

Because the supplier also offers quantity-based pricing on some products, the sensible comparison is:

regular price vs volume price vs promotional price

rather than assuming that “up to 30%” means every product receives exactly 30%.

How to Read a COA in 60 Seconds

If you're looking at a COA for the first time, use this sequence.

First: Find the compound

Does the name match the product?

Second: Find the lot

Does the lot match the physical batch?

Third: Find the test date

Is the certificate associated with a current/relevant batch?

Fourth: Find HPLC

What purity was actually measured?

Fifth: Find MS

Does the reported molecular mass support the expected identity?

Sixth: Find the laboratory

Who performed the analysis?

Seventh: Look for additional tests

Are there other analyses relevant to the project?

Eighth: Save the document

Keep the COA with your research records.

That's the basic workflow.

How to Read a COA in Five Minutes

If you have more time, go deeper.

Step 1: Compare the molecular information

Check:

molecular weight

formula

compound name

sequence/structural description

Do they make sense together?

Step 2: Examine the HPLC result

Don't just look at the percentage.

Look at the chromatographic information if supplied.

Step 3: Examine mass data

Compare reported mass with expected molecular mass while considering the analytical method and expected form of the molecule.

Step 4: Check the batch

Make sure the document isn't a generic certificate.

Step 5: Check the laboratory

Determine whether the testing source is identifiable.

Step 6: Look for inconsistencies

A mismatch between:

product page,
vial label,
COA,
and molecular specification

deserves clarification.

Common COA Mistakes Mistake 1: Looking only at the purity percentage

Purity is important.

It is not everything.

Mistake 2: Ignoring the lot number

A COA without a connection to your batch is weaker evidence.

Mistake 3: Treating HPLC as identity confirmation

HPLC and MS answer different questions.

Mistake 4: Treating “third-party tested” as self-proving

Find out who performed the test.

Mistake 5: Confusing research grade with pharmaceutical grade

Those terms should not be treated as interchangeable.

Mistake 6: Assuming a COA proves safety

It doesn't.

Mistake 7: Assuming a COA proves clinical efficacy

It doesn't.

Mistake 8: Ignoring storage

Analytical quality at the time of testing doesn't eliminate the importance of subsequent handling.

What a COA Cannot Tell You

Even a very good COA has boundaries.

A COA generally cannot by itself establish:

human safety,
therapeutic efficacy,
appropriate dosing,
pharmaceutical equivalence,
clinical benefit,
long-term stability,
or suitability for a particular biological experiment.

Those questions require other forms of evidence.

This is particularly important for retatrutide and cagrilintide, which remain research/investigational compounds rather than FDA-approved ingredients for an approved drug product. The FDA currently states that retatrutide and cagrilintide are not components of FDA-approved drugs and warns against their use in compounding. ([U.S. Food and Drug Administration][7])

Research Material Is Not the Same as an Approved Medicine

This distinction deserves its own section.

A research supplier may sell a material whose molecular name is identical to the active ingredient in an approved pharmaceutical.

That does not make the vial an approved pharmaceutical product.

Differences can include:

formulation,
excipients,
sterility,
manufacturing controls,
packaging,
regulatory review,
intended use,
and labeling.

American Peptides explicitly labels its products as Research Use Only and states that they are not intended for human or veterinary consumption. ([American Peptides][1])

That distinction should remain clear in any serious research article.

Why Retatrutide Needs Extra Regulatory Context

Retatrutide is a useful example of why scientific interest and regulatory status are separate concepts.

The molecule has generated substantial clinical research interest and is being studied as a multi-receptor agonist.

But research interest does not equal approval.

As of August 2026, the FDA's current public information continues to distinguish retatrutide from FDA-approved drug components, while the compound remains in development. ([U.S. Food and Drug Administration][7])

Therefore, a COA for research retatrutide should be interpreted as analytical documentation for research material, not as evidence of FDA approval.

Using Primary Research Alongside the COA

A COA tells you about the material.

Scientific literature tells you about the molecule and the research question.

You need both.

For example:

COA

→ What was tested?

Research paper

→ What does the scientific literature say about the compound?

Regulatory source

→ What is its current legal/regulatory status?

Experimental protocol

→ How was the compound evaluated in the particular study?

These are different evidence layers.

Your Research-Article Reference Cluster

For deeper reading across the compounds covered by this research cluster:

Retatrutide Research Guide 2026

Cagrilintide Research Guide 2026

Retatrutide + Cagrilintide Research Guide

Semaglutide Research Guide 2026

Tirzepatide Research Guide 2026

Semaglutide vs Tirzepatide vs Retatrutide

Semaglutide vs Tirzepatide vs Retatrutide comparison

Additional receptor comparison

Additional receptor comparison reference

Additional visual/reference resource

SeaArt reference

Research reference Gist

GitHub Gist research reference

Frequently Asked Questions About Peptide COAs What should a good research peptide COA contain?

A strong COA should identify the compound and lot, provide a testing date, identify the analytical methods, report actual results, and provide enough information to connect the certificate to the material being evaluated.

Is a lot-matched COA better than a generic peptide COA?

Yes. A lot-matched certificate connects the analytical results to a particular batch, making it more useful for traceability and research documentation.

What does HPLC purity mean for a research peptide?

HPLC purity describes the chromatographic purity result obtained under the stated analytical method. It should not be interpreted as a complete assessment of safety, sterility, or pharmaceutical quality.

What does mass spectrometry prove on a peptide COA?

Mass spectrometry provides molecular-mass information that can support the identity of the analyzed compound. It complements rather than replaces chromatographic purity testing.

Is 99% purity enough to prove a peptide is high quality?

No. Purity is one analytical characteristic. Researchers should also consider identity, lot traceability, testing provenance, storage, additional quality attributes, and the requirements of the specific experiment.

What does third-party tested mean?

It generally means an external laboratory performed the relevant analytical testing. The most useful documentation identifies the laboratory, method, date, lot, and actual result.

Can a COA prove a peptide is safe for human use?

No. A research-peptide COA is not evidence of human safety or regulatory approval.

Does a COA prove FDA approval?

No. Analytical documentation and regulatory approval are completely different things.

Is research-grade semaglutide the same as approved semaglutide medicine?

Not necessarily. Even when the molecular name is the same, research-use material and an approved pharmaceutical can differ in formulation, manufacturing controls, sterility, packaging, labeling, and regulatory status.

Is retatrutide FDA approved in 2026?

No. Retatrutide remains investigational, and FDA information continues to distinguish it from components of approved drugs. ([U.S. Food and Drug Administration][7])

What should I check first when reading a retatrutide COA?

Start with the compound name, lot number, testing laboratory, test date, HPLC result, mass-spectrometry result, and consistency between the COA and the product's stated molecular specifications.

Why should I keep the COA with my research records?

Because the lot-specific analytical record can help document exactly which material was associated with a particular experiment and improve reproducibility.

Does American Peptides publish lot-matched COAs?

Its current COA library states that it provides lot-matched certificates and lists multiple certificates for retatrutide, semaglutide, tirzepatide, cagrilintide-related products, and other research compounds. ([American Peptides][1])

Does American Peptides offer a discount code?

The supplied current promotion is LOOT10, advertised as providing up to 30% off.

How do I check the current LOOT10 offer?

Use the current offer page:

American Peptides LOOT10 offer

Apply the code where applicable and verify the actual discount displayed at checkout.

Does LOOT10 guarantee 30% off every research peptide?

No. The promotion is advertised as up to 30% off, so the applicable saving should be confirmed for the specific product, configuration, and current checkout conditions.

The Bottom Line: Read the Evidence, Not Just the Number

A peptide COA is most useful when you treat it as a traceability document, not a marketing badge.

The ideal chain is straightforward:

Correct compound

↓

Specific lot

↓

Named analytical testing

↓

HPLC purity

↓

Mass-spectrometry identity evidence

↓

Additional relevant testing

↓

Lot-matched COA

↓

Proper storage and documentation

That framework works whether you're evaluating retatrutide, semaglutide, tirzepatide, cagrilintide, or another research peptide.

And it works regardless of which supplier you're considering.

For American Peptides specifically, the current documentation system provides a useful starting point because the company publicly lists lot-matched COAs and identifies HPLC/mass-spectrometry testing for its research compounds. ([American Peptides][1])

Once the analytical and research requirements are satisfied, pricing becomes the final comparison rather than the first.

For the current supplied promotion, that means checking LOOT10 against the actual cart price and any applicable quantity pricing:

Check the current LOOT10 offer

The smartest research purchase isn't necessarily the one with the biggest discount.

It's the one where you can answer what you bought, which lot it came from, how it was tested, what the results were, and why that material fits the research question.

Research Peptide COA Guide 2026: How to Read HPLC, Mass Spectrometry, Purity & Batch Testing

Post a Reply